|
SFRS2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.40998324127395E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.49054118942149E-13 |
| Normal-vs-Stage2 |
9.678600E-03 |
| Normal-vs-Stage3 |
6.46860010000694E-10 |
| Normal-vs-Stage4 |
2.08339999996365E-06 |
| Stage1-vs-Stage2 |
2.448600E-01 |
| Stage1-vs-Stage3 |
2.379600E-01 |
| Stage1-vs-Stage4 |
8.490000E-01 |
| Stage2-vs-Stage3 |
8.893700E-02 |
| Stage2-vs-Stage4 |
3.961600E-01 |
| Stage3-vs-Stage4 |
5.271200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44089209850063E-15 |
| Normal-vs-AfricanAmerican |
9.63390001107456E-09 |
| Normal-vs-Asian |
5.586200E-02 |
| Caucasian-vs-AfricanAmerican |
2.554000E-01 |
| Caucasian-vs-Asian |
8.598200E-01 |
| AfricanAmerican-vs-Asian |
8.368200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44089209850063E-16 |
| Normal-vs-Female |
1.62796999999548E-05 |
| Male-vs-Female |
2.120500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.93500000028801E-07 |
| Normal-vs-Extreme_Weight |
1.69930736149126E-12 |
| Normal-vs-Obese |
6.27550011955691E-10 |
| Normal-vs-Extreme_Obese |
6.751000E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.669040E-01 |
| Normal_Weight-vs-Obese |
7.150600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.612200E-01 |
| Extreme_Weight-vs-Obese |
2.558800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.847000E-01 |
| Obese-vs-Extreme_Obese |
3.241600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.52692999999537E-05 |
| Normal-vs-Age(41-60Yrs) |
9.45665767915216E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(81-100Yrs) |
9.90979999999642E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.053000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.285750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.430000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.456200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.715620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.100000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.65178981603731E-12 |
| Normal-VS-Type2 PRCC |
1.62592161956354E-12 |
| Normal-VS-KIRP CIMP |
1.38289999995767E-06 |
| Normal-VS-Unclassified PRCC |
2.58540000519503E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.337370E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.208600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.253400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.443400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.239200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.763000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70419234279962E-12 |
| Normal-vs-N1 |
2.38520314610469E-11 |
| Normal-vs-N2 |
5.42949996074071E-09 |
| N0-vs-N1 |
9.109400E-01 |
| N0-vs-N2 |
3.619800E-02 |
| N1-vs-N2 |
1.470390E-02 |
|
|
